Vivos Therapeutics Inc./$VVOS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
- Ticker
- $VVOS
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 268
- Headquarters
- Littleton, United States
- Website
- www.vivos.com
VVOS Metrics
BasicAdvanced
$1.8M
-
-$1.83
6.09
-
Price and volume
Market cap
$1.8M
Beta
6.09
52-week high
$2.72
52-week low
$0.09
Average daily volume
5.4M
Financial strength
Current ratio
0.207
Quick ratio
0.158
Long term debt to equity
-0.975
Total debt to equity
-3.137
Interest coverage (TTM)
-10.25%
Profitability
EBITDA (TTM)
-20.763
Gross margin (TTM)
61.90%
Net profit margin (TTM)
-121.79%
Operating margin (TTM)
-107.90%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-56.19%
Return on equity (TTM)
-8,585.26%
Valuation
Price to revenue (TTM)
0.06
Price to book
-0.27
Price to tangible book (TTM)
-0.08
Price to free cash flow (TTM)
-0.066
Free cash flow yield (TTM)
-1,507.61%
Free cash flow per share (TTM)
-1.364
Growth
Revenue change (TTM)
45.22%
Earnings per share change (TTM)
2.76%
3-year revenue growth (CAGR)
10.60%
3-year earnings per share growth (CAGR)
-53.07%
What the Analysts think about VVOS
Analyst ratings (Buy, Hold, Sell) for Vivos Therapeutics Inc. stock.
Analyst projections of the future price of Vivos Therapeutics Inc. stock.
VVOS Financial Performance
Revenues and expenses
VVOS Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.